Cell Growth & Differentiation, Vol 5, Issue 3 305-311, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Developmental expression of the RET protooncogene

V Avantaggiato, NA Dathan, M Grieco, N Fabien, D Lazzaro, A Fusco, A Simeone and M Santoro
Istituto Internazionale di Genetica e Biofisica, Consiglio Nazionale delle Ricerche, Naples, Italy.

The RET protooncogene encodes a transmembrane protein of the receptor-type tyrosine kinase family whose ligand has not yet been identified. Its activation in vivo is restricted to human carcinomas of the thyroid. In order to learn more about the possible role played by RET during normal development, we have examined its expression by performing in situ hybridization experiments on mouse embryos. Here, we show that the RET protooncogene is expressed during mouse embryogenesis in an unusual temporal and spatial manner. In fact, its expression was first detected around day 10 of gestation in the basal plate of the neural tube and in the developing encephalic ganglia, and later its pattern of expression was definitely established in neural structures, mostly in neural crest derivatives (spinal and encephalic ganglia). As far as the central nervous system is concerned, RET expression was confined to the ventral part of the midbrain from 12.5 days postcoitum (dpc) until birth. RET was also found to be expressed within structures of sensory organs such as the ganglial layer of the retina and the olfactory epithelium. A peculiar pattern of RET expression was clearly observed in the wall of the gut and in the nephrogenic zone of the developing kidney cortex, specifically in the metanephrogenic vesicles. Finally, RET was found to be expressed in the liver mostly between 12.5 dpc and 14.5 dpc. In conclusion, its expression in the early stages of embryogenesis suggests that RET may play a role in the differentiation of specific neural structures and the excretory system.

This article has been cited by other articles:

				N. Akeno-Stuart, M. Croyle, J. A. Knauf, R. Malaguarnera, D. Vitagliano, M. Santoro, C. Stephan, K. Grosios, M. Wartmann, R. Cozens, et al. The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells Cancer Res., July 15, 2007; 67(14): 6956 - 6964. [Abstract] [Full Text] [PDF]

				O. Oppenheimer, N.-K. Cheung, and W. L. Gerald The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma Mol. Cancer Ther., April 1, 2007; 6(4): 1300 - 1309. [Abstract] [Full Text] [PDF]

				V. Vargas-Leal, R. Bruno, T. Derfuss, M. Krumbholz, R. Hohlfeld, and E. Meinl Expression and Function of Glial Cell Line-Derived Neurotrophic Factor Family Ligands and Their Receptors on Human Immune Cells J. Immunol., August 15, 2005; 175(4): 2301 - 2308. [Abstract] [Full Text] [PDF]

				S. M. Myers and L. M. Mulligan The RET Receptor Is Linked to Stress Response Pathways Cancer Res., July 1, 2004; 64(13): 4453 - 4463. [Abstract] [Full Text] [PDF]

				D. Lang and J. A. Epstein Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer Hum. Mol. Genet., April 15, 2003; 12(8): 937 - 945. [Abstract] [Full Text] [PDF]

				H. H. Simon, H. Saueressig, W. Wurst, M. D. Goulding, and D. D. M. O'Leary Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes J. Neurosci., May 1, 2001; 21(9): 3126 - 3134. [Abstract] [Full Text] [PDF]

				L. Quadro, O. Fattoruso, M. P. Cosma, U. Verga, A. Porcellini, A. Libroia, and V. Colantuoni Loss of Heterozygosity at the RET Protooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 239 - 244. [Abstract] [Full Text]

				S. Klugbauer, A. Jauch, E. Lengfelder, E. Demidchik, and H. M. Rabes A Novel Type of RET Rearrangement (PTC8) in Childhood Papillary Thyroid Carcinomas and Characterization of the Involved Gene (RFG8) Cancer Res., December 1, 2000; 60(24): 7028 - 7032. [Abstract] [Full Text]

				J. R Hansford and L. M Mulligan Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J. Med. Genet., November 1, 2000; 37(11): 817 - 827. [Abstract] [Full Text]

				H. M. Rabes, E. P. Demidchik, J. D. Sidorow, E. Lengfelder, C. Beimfohr, D. Hoelzel, and S. Klugbauer Pattern of Radiation-induced RET and NTRK1 Rearrangements in 191 Post-Chernobyl Papillary Thyroid Carcinomas: Biological, Phenotypic, and Clinical Implications Clin. Cancer Res., March 1, 2000; 6(3): 1093 - 1103. [Abstract] [Full Text]

				A. Tessitore, A. A. Sinisi, D. Pasquali, M. Cardone, D. Vitale, A. Bellastella, and V. Colantuoni A Novel Case of Multiple Endocrine Neoplasia Type 2A Associated with Two de Novo Mutations of the RETProtooncogene J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3522 - 3527. [Abstract] [Full Text] [PDF]

				S. M Myers, R. Salomon, A. Goessling, A. Pelet, C. Eng, A. von Deimling, S. Lyonnet, and L. M Mulligan Investigation of germline GFRalpha -1 mutations in Hirschsprung disease J. Med. Genet., March 1, 1999; 36(3): 217 - 220. [Abstract] [Full Text]

				S Taraviras, C. Marcos-Gutierrez, P Durbec, H Jani, M Grigoriou, M Sukumaran, L. Wang, M Hynes, G Raisman, and V Pachnis Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system Development, January 6, 1999; 126(12): 2785 - 2797. [Abstract] [PDF]

				K. Krieglstein, P. Henheik, L. Farkas, J. Jaszai, D. Galter, K. Krohn, and K. Unsicker Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-beta for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons J. Neurosci., December 1, 1998; 18(23): 9822 - 9834. [Abstract] [Full Text] [PDF]

				M. P. Cosma, M. Cardone, F. Carlomagno, and V. Colantuoni Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism Mol. Cell. Biol., June 1, 1998; 18(6): 3321 - 3329. [Abstract] [Full Text]

				C. A. Worby, Q. C. Vega, H. H.-J. Chao, A. F. Seasholtz, R. C. Thompson, and J. E. Dixon Identification and Characterization of GFRalpha -3, a Novel Co-receptor Belonging to the Glial Cell Line-derived Neurotrophic Receptor Family J. Biol. Chem., February 6, 1998; 273(6): 3502 - 3508. [Abstract] [Full Text] [PDF]

				V. Gattei, A. Celetti, A. Cerrato, M. Degan, A. De Iuliis, F. M. Rossi, G. Chiappetta, C. Consales, S. Improta, V. Zagonel, et al. Expression of the RET Receptor Tyrosine Kinase and GDNFR-alpha in Normal and Leukemic Human Hematopoietic Cells and Stromal Cells of the Bone Marrow Microenvironment Blood, April 15, 1997; 89(8): 2925 - 2937. [Abstract] [Full Text] [PDF]

				A Schuchardt, V D'Agati, V Pachnis, and F Costantini Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development Development, January 6, 1996; 122(6): 1919 - 1929. [Abstract] [PDF]

				J. Grimm, M. Sachs, S. Britsch, S. Di Cesare, T. Schwarz-Romond, K. Alitalo, and W. Birchmeier Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation J. Cell Biol., July 23, 2001; 154(2): 345 - 354. [Abstract] [Full Text] [PDF]